The cleanest read-through is not “one bad guide,” but a valuation reset for software names where monetization is still being questioned. INTU’s miss on the outer-year outlook is a warning that premium multiples can compress fast when management teams fail to prove durable uplift from pricing or AI-led attach; that pressure should spill into NOW, WDAY, CRM, SAP and ZM on any rally, because the market will now demand harder evidence of re-acceleration. IGV looks vulnerable to a further 5-8% derating over the next 1-3 months if subsequent prints confirm slower enterprise conversion.

BSX is a different kind of problem: a cyber-driven product/access disruption is first a revenue timing issue, then a potential service and regulatory overhang if restoration drags. The second-order effect is share shift to larger peers with redundant manufacturing and service infrastructure—MDT, JNJ, and ABT are the obvious beneficiaries if hospitals need immediate substitution. The tail risk is that this turns from a one-quarter hiccup into a multi-quarter trust issue; if management cannot restore access quickly, the market will start capitalizing a permanent mix hit rather than a transitory outage.

The positive outliers matter because they suggest dispersion, not a broad risk-on/risk-off move. SEDG’s policy-driven upside is the kind of catalyst that can re-rate a beaten-up name if pricing power actually improves, while SMTC’s beat is more useful as a signal that selective semis remain operationally tight even as software multiple risk rises. Contrarian take: the market may be overreacting to software as a group, but underreacting to the duration risk in BSX; the former is a valuation problem, the latter can become an earnings problem.